← Back to patent-cliff list
CAS 59285-13-1
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-isocyanatotetrahydrofuran-3,4-diyl diacetate
Codes: AZAC-001
Application context (from source-drug indications)
幼年型粒单核细胞白血病AzacitidineAcute myeloid leukaemiaAzacitidineMyelodysplastic syndromeAzacitidineChronic myeloid leukaemiaAzacitidineChronic myelomonocytic leukaemiaAzacitidine脑性瘫痪Azacitidine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Azacitidine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-isocyanatotetrahydrofuran-3,4-diyl diacetate→methyl carbamimidothioate→(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(3-((E)-amino(methylthio)methylene)ureido)tetrahydrofuran-3,4-diyl diacetate→(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-(methylthio)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.